文献速递糖尿病

第二代抗精神病药阿立哌唑调节胰岛血清素能系统并诱导雌性小鼠β细胞功能障碍

The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice.
PubMed 文献 · Diabetologia · 2021-12-21

研究分析奥氮平和阿立哌唑对雌性小鼠代谢状态及胰岛功能的影响。两种药物均致体重增加、糖耐量异常和胰岛素分泌受损;阿立哌唑作用更强,可能通过增加色氨酸羟化酶1表达诱导β细胞血清素生成并抑制钙离子流。

要点

  • 奥氮平和阿立哌唑喂养6个月均致雌性小鼠体重增加、糖耐量异常和胰岛素分泌受损。
  • 阿立哌唑较奥氮平代谢影响更强,与β细胞血清素生成增加及钙离子流抑制相关。
  • 阿立哌唑增加β细胞大小和数量并激活mTORC1/S6信号,但未阻止β细胞功能障碍。

核心结论

  • 奥氮平和阿立哌唑均诱导体重增加和β细胞功能障碍,导致糖耐量异常;阿立哌唑代谢影响更强,可能与其调节血清素能系统有关。
  • 作者认为治疗患者时应考虑第二代抗精神病药对胰岛功能的不良代谢影响,因这些药物可能增加代谢综合征和糖尿病的风险。

研究设计与样本

  • 研究为动物实验,使用12周龄雌性B6;129小鼠,分别喂养含奥氮平或阿立哌唑的饲料(5.5-6.0 mg kg-1 day-1)6个月。

主要发现

  • 与对照饲料组相比,奥氮平组体重增加p<0.01,阿立哌唑组体重增加p<0.05。
  • 与对照饲料组相比,奥氮平和阿立哌唑组均出现糖耐量异常(p<0.01)和胰岛素分泌受损(p<0.05)。
  • 阿立哌唑而非奥氮平诱导β细胞血清素生成,可能通过增加色氨酸羟化酶1表达,并抑制钙离子流。
  • 与对照饲料组相比,阿立哌唑增加β细胞大小(p<0.05)和数量(p<0.01),并激活mTORC1/S6信号,但未阻止β细胞功能障碍。

临床怎么用

  • 作者认为治疗患者时应考虑第二代抗精神病药对胰岛功能的不良代谢影响,因这些药物可能增加代谢综合征和糖尿病的风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Second-generation antipsychotic (SGA) drugs have been associated with the development of type 2 diabetes and the metabolic syndrome in patients with schizophrenia. In this study, we aimed to investigate the effects of two different SGA drugs, olanzapine and aripiprazole, on metabolic state and islet function and plasticity. METHODS: We analysed the functional adaptation of beta cells in 12-week-old B6;129 female mice fed an olanzapine- or aripiprazole-supplemented diet (5.5-6.0 mg kg-1 day-1) for 6 months. Glucose and insulin tolerance tests, in vivo glucose-stimulated insulin secretion and indirect calorimetry were performed at the end of the study. The effects of SGAs on beta cell plasticity and islet serotonin levels were assessed by transcriptomic analysis and immunofluorescence. Insulin secretion was assessed by static incubations and Ca2+ fluxes by imaging techniques. RESULTS: Treatment of female mice with olanzapine or aripiprazole for 6 months induced weight gain (p<0.01 and p<0.05, respectively), glucose intolerance (p<0.01) and impaired insulin secretion (p<0.05) vs mice fed a control chow diet. Aripiprazole, but not olanzapine, induced serotonin production in beta cells vs controls, likely by increasing tryptophan hydroxylase 1 (TPH1) expression, and inhibited Ca2+ flux. Of note, aripiprazole increased beta cell size (p<0.05) and mass (p<0.01) vs mice fed a control chow diet, along with activation of mechanistic target of rapamycin complex 1 (mTORC1)/S6 signalling, without preventing beta cell dysfunction. CONCLUSIONS/INTERPRETATION: Both SGAs induced weight gain and beta cell dysfunction, leading to glucose intolerance; however, aripiprazole had a more potent effect in terms of metabolic alterations, which was likely a result of its ability to modulate the serotonergic system. The deleterious metabolic effects of SGAs on islet function should be considered while treating patients as these drugs may increase the risk for development of the metabolic syndrome and diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Grajales D, Vázquez P, Ruíz-Rosario M, et al. The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice. Diabetologia. 2021. PMID: 34932133. doi:10.1007/s00125-021-05630-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。